pyrazolanthrone has been researched along with Prostatic Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Nazim, UM; Park, SY; Yin, H | 1 |
| Chung, KH; Jung, EJ; Kim, CW | 1 |
| Gao, HW; He, YY; Khan, M; Li, YM; Ma, TH; Yang, JB; Yao, M | 1 |
| Altieri, DC; Davis, RJ; Deming, D; Dicker, AP; Duffy, A; Gabrilovich, D; Languino, LR; Liu, Q; Lu, H; McCue, P; Rodeck, U; Sayeed, A | 1 |
| Chen, SP; Chen, YL; Chiu, SC; Harn, HJ; Huang, SY; Lin, SZ; Pang, CY; Wang, MJ; Yang, HH | 1 |
| Ehrlich, M; Pinkas-Kramarski, R; Schmukler, E; Shai, B | 1 |
| Agarwal, C; Agarwal, R; Tyagi, A | 1 |
| Cotter, TG; Curtin, JF | 1 |
| Cho, JY; Correa, RG; Libermann, TA; Wang, Y; Zerbini, LF | 1 |
| Aller, P; Fernández, C; Fraile, B; García-Tuñón, I; Paniagua, R; Ricote, M; Royuela, M | 1 |
| Hakariya, T; Igawa, T; Kanetake, H; Sakai, H; Shida, Y | 1 |
| Cáceres, M; Guerrero, J; Martínez, J; Smith, PC; Tobar, N | 1 |
| Hagberg, M; Johansson, V; Kjellberg, C; Larsson, D; Malek, N; Senneberg, E; Tahmasebifar, N | 1 |
13 other study(ies) available for pyrazolanthrone and Prostatic Neoplasms
| Article | Year |
|---|---|
Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway.
Topics: Anthracenes; Autophagy; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2020 |
Identification of simvastatin-regulated targets associated with JNK activation in DU145 human prostate cancer cell death signaling.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Docetaxel; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; JNK Mitogen-Activated Protein Kinases; Male; Phosphorylation; Prostatic Neoplasms; Proteomics; Signal Transduction; Simvastatin; Taxoids | 2017 |
Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Anthracenes; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cinnamates; Cyclin E; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; G1 Phase; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase Kinase 5; Membrane Potential, Mitochondrial; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reactive Oxygen Species; Resting Phase, Cell Cycle; Saponins; Thiourea; Triterpenes | 2016 |
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
Topics: Adenocarcinoma; Animals; Anthracenes; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Profiling; Humans; Integrin beta1; JNK Mitogen-Activated Protein Kinases; Male; Mice, Transgenic; Phosphorylation; Prostatic Neoplasms; Radiation Dose Hypofractionation; Receptor, IGF Type 1; Tumor Burden | 2016 |
Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells.
Topics: 4-Butyrolactone; Anthracenes; Benzodioxoles; Blotting, Western; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Growth Differentiation Factor 15; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Signal Transduction; Tumor Suppressor Protein p53 | 2011 |
Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition.
Topics: Acetylcysteine; Adenine; Anthracenes; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Death; Cell Line, Tumor; Humans; Male; MAP Kinase Signaling System; Membrane Proteins; Neoplasms, Hormone-Dependent; Neuregulins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Recombinant Proteins; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Adenocarcinoma; Anthracenes; Apoptosis; Cell Division; Cell-Free System; Culture Media, Serum-Free; DNA-Binding Proteins; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; ets-Domain Protein Elk-1; Flavonoids; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Plant Extracts; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Seeds; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Vitis | 2003 |
JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells.
Topics: Anthracenes; Apoptosis; Arabidopsis Proteins; Blotting, Western; Carrier Proteins; Caspase 8; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; fas Receptor; Fatty Acid Desaturases; Humans; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Male; Mitogen-Activated Protein Kinases; Models, Biological; Phosphorylation; Precipitin Tests; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2004 |
Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.
Topics: Adenoviridae; Anthracenes; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Cytoplasm; DNA; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Immunoprecipitation; Male; MAP Kinase Kinase 4; Mutation; NF-kappa B; Nuclear Proteins; Oligonucleotides; Phosphorylation; Plasmids; Prostatic Neoplasms; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Serine; Signal Transduction; Temperature; Transfection; Tumor Suppressor Protein p53 | 2005 |
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cells.
Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Line, Tumor; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha | 2006 |
p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion.
Topics: Androgens; Anthracenes; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Interleukin-6; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Pyridines; Ritodrine | 2007 |
c-jun-NH2JNK mediates invasive potential and EGFR activation by regulating the expression of HB-EGF in a urokinase-stimulated pathway.
Topics: Anthracenes; Autocrine Communication; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Male; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Up-Regulation; Urokinase-Type Plasminogen Activator | 2008 |
Membrane initiated signaling by 1,25alpha-dihydroxyvitamin D3 in LNCaP prostate cancer cells.
Topics: Anthracenes; Cell Proliferation; Drug Therapy, Combination; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Signal Transduction; Tumor Cells, Cultured; Vitamin D | 2008 |